UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preference for etanercept pen versus syringe in patients with chronic arthritis. Nurse education workshop

Enfermeria clinica, 2013-07, Vol.23 (4), p.164

2013

Volltextzugriff (PDF)

"Switching adalimumab from syringe to pen. Expected outcomes"

Expert opinion on biological therapy, 2012-06, Vol.12 (6), p.805-806

2012

Volltextzugriff (PDF)

Sweet syndrome associated with myelodysplastic syndrome: report of a case. Review of the literature

Reumatologia clinica, 2013-07, Vol.9 (4), p.246

2013

Volltextzugriff (PDF)

Experience of monitoring subcutaneous biological treatment (adalimumab) by nurses in chronic inflammatory diseases

Reumatologia clinica, 2011-09, Vol.7 (5), p.349

2011

Volltextzugriff (PDF)

Monitorización por enfermería de la administración de tratamientos biológicos subcutáneos (adalimumab) en enfermedades inflamatorias crónicas

Reumatología clinica, 2011-09, Vol.7 (5), p.349-350

2011

Volltextzugriff (PDF)

Sjögren's Syndrome

Reumatología clinica, 2008-03, Vol.4 Suppl 1, p.22-27

2008

Volltextzugriff (PDF)

Síndrome de Sweet asociado a síndrome mielodisplásico: a propósito de un caso. Revisión de la literatura

Reumatología clinica, 2013-07, Vol.9 (4), p.246-247

2013

Volltextzugriff (PDF)

Sweet Syndrome Associated With Myelodysplastic Syndrome: Report of a Case. Review of the Literature

Reumatología clinica (Barcelona), 2013-07, Vol.9 (4), p.246-247

2013

Volltextzugriff (PDF)

Experience of Monitoring Subcutaneous Biological Treatment (Adalimumab) by Nurses in Chronic Inflammatory Diseases

Reumatología clinica (Barcelona), 2011-09, Vol.7 (5), p.349-350

2011

Volltextzugriff (PDF)

Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study

Arthritis research & therapy, 2019-04, Vol.21 (1), p.88-88, Article 88

2019

Volltextzugriff (PDF)

Diagnostic and Therapeutic Delay of Rheumatoid Arthritis and its Relationship With Health Care Devices in Catalonia. The AUDIT Study

Reumatología clinica (Barcelona), 2016-05, Vol.12 (3), p.146-150

2016

Volltextzugriff (PDF)

Preferencia de pluma de etanercept respecto a jeringa en pacientes con artritis crónica. Taller educativo por enfermería

Enfermería clínica, 2013-07, Vol.23 (4), p.164-169

2013

Volltextzugriff (PDF)

Síndrome de Sjögren

Reumatología clinica, 2008, Vol.4, p.22-27

2008

Volltextzugriff (PDF)

Acromegalia

Reumatología clinica, 2013-03, Vol.9 (2), p.128-129

2013

Volltextzugriff (PDF)

Acromegaly

Reumatologia clinica, 2013-03, Vol.9 (2), p.128

2013

Volltextzugriff (PDF)

Acromegaly

Reumatología clinica (Barcelona), 2013-03, Vol.9 (2), p.128-129

2013

Volltextzugriff (PDF)

VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist

Reumatologia clinica, 2016-11, Vol.12 (6), p.319

2016

Volltextzugriff (PDF)

Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool

EJD. European journal of dermatology, 2015, Vol.25 (1), p.57-63

2015

Volltextzugriff (PDF)

Estudio VARIAR: VAloración de la eficacia y seguridad a corto plazo en artritis reumatoide del uso de RItuximab comparado con Antagonistas del factor de necrosis tumoral alfa en segunda línea terapéutica en pacientes con artritis reumatoide Refractarios a un primer antagonista del factor de necrosis tumoral alfa

Reumatología clinica, 2016-11, Vol.12 (6), p.319-322

2016

Volltextzugriff (PDF)

VARIAR Study: Assessment of Short-term Efficacy and Safety of Rituximab Compared to an Tumor Necrosis Factor Alpha Antagonists as Second-line Drug Therapy in Patients With Rheumatoid Arthritis Refractory to a First Tumor Necrosis Factor Alpha Antagonist

Reumatología clinica (Barcelona), 2016-11, Vol.12 (6), p.319-322

2016

Volltextzugriff (PDF)

On-treatment safety and efficacy and short-term efficacy of 1--34 parathyroid hormone treatment in severe osteoporosis

Bone Abstracts, 2014-05

2014

Volltextzugriff (PDF)

Oxytocin Administration in Low-Risk Women, a Retrospective Analysis of Birth and Neonatal Outcomes

International journal of environmental research and public health, 2021-04, Vol.18 (8), p.4375

2021

Volltextzugriff (PDF)

Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study

Annals of the rheumatic diseases, 2012-11, Vol.71 (11), p.1861-1864

2012

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(25)

Sprache

Englisch
(15)
Spanisch
(14)

Erscheinungsjahr

n.n

Thema

Rheumatology
(13)
Humans
(11)
Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Female
(8)
Middle Aged
(8)
Male
(7)
Rheumatoid Arthritis
(6)
Arthritis, Rheumatoid - Drug Therapy
(5)
Adult
(4)
Aged
(4)
Antirheumatic Agents - Therapeutic Use
(4)
Ankylosing Spondylitis
(3)
Arthritis
(3)
Artritis Reumatoide
(3)
Prospective Studies
(3)
Psoriatic Arthritis
(3)
Rituximab
(3)
Severity Of Illness Index
(3)
Adalimumab
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT study

Preference for etanercept pen versus syringe in patients with chronic arthritis. Nurse education workshop

"Switching adalimumab from syringe to pen. Expected outcomes"

Sweet syndrome associated with myelodysplastic syndrome: report of a case. Review of the literature

Experience of monitoring subcutaneous biological treatment (adalimumab) by nurses in chronic inflammatory diseases

Monitorización por enfermería de la administración de tratamientos biológicos subcutáneos (adalimumab) en enfermedades inflamatorias crónicas

Sjögren's Syndrome

Síndrome de Sweet asociado a síndrome mielodisplásico: a propósito de un caso. Revisión de la literatura

Retraso diagnóstico y terapéutico de la artritis reumatoide y su relación con dispositivos asistenciales en Catalunya. Estudio AUDIT

Sweet Syndrome Associated With Myelodysplastic Syndrome: Report of a Case. Review of the Literature

Experience of Monitoring Subcutaneous Biological Treatment (Adalimumab) by Nurses in Chronic Inflammatory Diseases

Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study

Diagnostic and Therapeutic Delay of Rheumatoid Arthritis and its Relationship With Health Care Devices in Catalonia. The AUDIT Study

Preferencia de pluma de etanercept respecto a jeringa en pacientes con artritis crónica. Taller educativo por enfermería

Síndrome de Sjögren

Acromegalia

Acromegaly

Acromegaly

VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist

Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool

VARIAR Study: Assessment of Short-term Efficacy and Safety of Rituximab Compared to an Tumor Necrosis Factor Alpha Antagonists as Second-line Drug Therapy in Patients With Rheumatoid Arthritis Refractory to a First Tumor Necrosis Factor Alpha Antagonist

On-treatment safety and efficacy and short-term efficacy of 1--34 parathyroid hormone treatment in severe osteoporosis

Oxytocin Administration in Low-Risk Women, a Retrospective Analysis of Birth and Neonatal Outcomes

Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study

Suchergebnisse filtern